Evidence map›Paper›PMID 40667721›Full record

ArticleFEBS letters2025

Mycobacterium tuberculosis sulfurtransferase SseA is activated by its neighboring gene product Rv3284.

Giulia Di Napoli, Alex Fissore, Edoardo Salladini, Eleonora Raccuia, Simonetta Oliaro-Bosso, Alessia Ruggiero, Rita Berisio, Milagros Medina, Adrian Velazquez-Campoy, Salvatore Adinolfi and 1 more

Abstract read
In one paragraph

Article in FEBS letters, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

11 authors.

Giulia Di NapoliDepartment of Drug Science and Technology, University of Turin, Turin, Italy.
Alex FissoreDepartment of Drug Science and Technology, University of Turin, Turin, Italy.
Edoardo SalladiniDepartment of Drug Science and Technology, University of Turin, Turin, Italy.ORCID https://orcid.org/0000-0002-5152-5953
Eleonora RaccuiaDepartment of Drug Science and Technology, University of Turin, Turin, Italy.
Simonetta Oliaro-BossoDepartment of Drug Science and Technology, University of Turin, Turin, Italy.
Alessia RuggieroInstitute of Biostructures and Bioimaging, CNR, Naples, Italy.
Rita BerisioInstitute of Biostructures and Bioimaging, CNR, Naples, Italy.ORCID https://orcid.org/0000-0001-5025-6483
Milagros MedinaDepartment of Biochemistry and Molecular and Cellular Biology, School of Sciences, and Institute for Biocomputation and Physics of Complex Systems, University of Zaragoza, Zaragoza, Spain.ORCID https://orcid.org/0000-0001-8743-0182
Adrian Velazquez-CampoyDepartment of Biochemistry and Molecular and Cellular Biology, School of Sciences, and Institute for Biocomputation and Physics of Complex Systems, University of Zaragoza, Zaragoza, Spain.
Salvatore AdinolfiDepartment of Drug Science and Technology, University of Turin, Turin, Italy.
Mauro MarengoDepartment of Drug Science and Technology, University of Turin, Turin, Italy.ORCID https://orcid.org/0000-0002-5389-3979

Funding

European Commission CUP B53C20040570005European Commission CUP B53D23033100001European Union Horizon 2020 Research and Innovation Program 101004806European Union Horizon 2020 Research and Innovation Program MOSBRI-2022-134European Union Horizon 2020 Research and Innovation Program MOSBRI-23-185Government of Aragón-FEDER E35_23RThe Spanish State Research Agency and the Spanish Federation of Rare Diseases (FEDER) PID2022-136369NB-I00Università degli Studi di Torino ADIS_RILO_21_01Università degli Studi di Torino MARM_GFI_22_01_F_01Università degli Studi di Torino MARM_RILO_22_05Università degli Studi di Torino OLIS_RILO_21_02
6 · The paper itself

Abstract

Tuberculosis remains a critical global health challenge, which underscores the need for new therapeutic targets. A potential drug target is the rhodanese-like thiosulfate sulfurtransferase SseA, which plays a role in macrophage infection by Mycobacterium tuberculosis (Mtb) and its resistance to oxidative stress. In our research, we identified a protein (Rv3284), herein referred to as SufE

Indexed as

Bacterial ProteinsMycobacterium tuberculosisSulfurtransferasesThiosulfate SulfurtransferaseAmino Acid SequenceEnzyme ActivationHumansModels, MolecularProtein BindingBacterial ProteinsSulfurtransferasesThiosulfate SulfurtransferaseenzymeMycobacterium tuberculosisSseASufEMtbthiosulfate sulfurtransferase

Identifiers

PMID40667721
PMCPMC12375888

What Socratic holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.